Clinical trial
Metabolic Modulation as Treatment in Acute Heart Failure
NCT00449423 · University of Aarhus, Other · Terminated
Key facts
| NCT number | NCT00449423 |
|---|---|
| Title | Metabolic Modulation as Treatment in Acute Heart Failure |
| Official title | Metabolic Modulation as Treatment in Acute Heart Failure |
| Acronym | MEMO |
| Lead sponsor | University of Aarhus, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Heart Failure |
| Intervention type | Drug |
| Interventions | acipimox |
| Enrollment | 32 |
| Start date | Mar 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Mar 20, 2007 |
| Last update posted | Oct 25, 2007 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: